• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION NEPHROMAX; CATHETER, NEPHROSTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION NEPHROMAX; CATHETER, NEPHROSTOMY Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Renal Failure (2041)
Event Date 09/01/2020
Event Type  Injury  
Manufacturer Narrative
Date of event: the exact date is unknown; however, it was reported that the event occurred in (b)(6) 2020.The complainant was unable to report the device suspected upn and lot number; therefore, the manufacture date and expiration date are unknown.Imdrf patient codes e130501 and e0506 capture the reportable event of acute kidney injury and hemorrhage.Imdrf impact codes f19 and f23 capture the reportable event of surgical intervention and unexpected medical intervention.
 
Event Description
This report pertains to one of two devices used in the same patient and procedure.It was reported to boston scientific corporation that a nephromax balloon and a percutaneous access needle were used during a left percutaneous nephrolithotomy procedure performed in (b)(6) 2020.The patient experienced hemorrhage and acute kidney injury (aki), requiring transfusion and interventional radiology (ir) embolization.
 
Manufacturer Narrative
Block b3: date of event: the exact date is unknown; however, it was reported that the event occurred in (b)(6) 2020.Block d4, h4: the complainant was unable to report the device suspected upn and lot number; therefore, the manufacture date and expiration date are unknown.Block h6: imdrf patient codes e130501 and e0506 capture the reportable event of acute kidney injury and hemorrhage.Imdrf impact codes f19 and f2302 capture the reportable event of surgical intervention and blood transfusion.Block h11: correction - block h6 (impact code) has been corrected.
 
Event Description
Note: this report pertains to one of two devices used in the same patient and procedure.It was reported to boston scientific corporation that a nephromax balloon and a percutaneous access needle were used during a left percutaneous nephrolithotomy procedure performed in (b)(6) 2020.The patient experienced hemorrhage and acute kidney injury (aki), requiring transfusion and interventional radiology (ir) embolization.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEPHROMAX
Type of Device
CATHETER, NEPHROSTOMY
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC IRELAND LIMITED
ballybrit business park
galway
EI  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key16323742
MDR Text Key309043358
Report Number3005099803-2023-00629
Device Sequence Number1
Product Code LJE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K121614
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/14/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/17/2023
Initial Date FDA Received02/08/2023
Supplement Dates Manufacturer Received02/14/2023
Supplement Dates FDA Received02/14/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age79 YR
Patient SexFemale
Patient RaceWhite
-
-